HealthEquity Inc Forecast, price target & analysts
HealthEquity Inc Target price 2026 - Analyst rating & recommendation
HealthEquity Inc Classifications & Recommendation
HealthEquity Inc Price Target
| Target Price | $117.30 |
| Price | $92.61 |
| Potential |
26.66%
register free of charge
|
| Number of Estimates | 17 |
|
17 Analysts have issued a price target HealthEquity Inc 2027 .
The average HealthEquity Inc target price is $117.30.
This is
26.66%
register free of charge
$149.10
61.00%
register free of charge
$106.05
14.51%
register free of charge
|
|
| A rating was issued by 20 analysts: 19 Analysts recommend HealthEquity Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the HealthEquity Inc stock has an average upside potential 2027 of
26.66%
register free of charge
|
Sales and Margin forecast 2027, 2028 & 2029
| Jan '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.31 | 1.43 |
| 9.47% | 8.95% | |
| EBITDA Margin | 33.15% | 44.80% |
| 26.37% | 35.13% | |
| Net Margin | 16.38% | 27.65% |
| 103.29% | 68.76% |
17 Analysts have issued a sales forecast HealthEquity Inc 2027 . The average HealthEquity Inc sales estimate is
This results in the following potential growth metrics:
17 Analysts have issued an HealthEquity Inc EBITDA forecast 2027. The average HealthEquity Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
17 HealthEquity Inc Analysts have issued a net profit forecast 2027. The average HealthEquity Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 & 2029
| Jan '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 2.46 | 4.77 |
| 125.69% | 93.90% | |
| P/E | 19.40 | |
| EV/Sales | 5.82 |
17 Analysts have issued a HealthEquity Inc forecast for earnings per share. The average HealthEquity Inc EPS is
This results in the following potential growth metrics and future valuations:
HealthEquity Inc...
Current HealthEquity Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Barclays |
Locked
➜
Locked
|
Locked | Sep 18 2026 |
| Deutsche Bank |
Locked
➜
Locked
|
Locked | Aug 31 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Aug 28 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Jul 24 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Jun 03 2026 |
| Citizens |
Locked
➜
Locked
|
Locked | Jun 01 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | May 29 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Barclays:
Locked
➜
Locked
|
Sep 18 2026 |
|
Locked
Deutsche Bank:
Locked
➜
Locked
|
Aug 31 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Aug 28 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Jul 24 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Jun 03 2026 |
|
Locked
Citizens:
Locked
➜
Locked
|
Jun 01 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
May 29 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
